Trials / Unknown
UnknownNCT03282253
Elevated Stearoyl-CoA Desaturase-1 Expression Predicts the Disease Severity of Severe Acute Pancreatitis
Elevated Stearoyl-CoA Desaturase-1 Expression Predicts the Disease Severity and Clinical Outcomes of Severe Acute Pancreatitis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 216 (estimated)
- Sponsor
- Nanjing University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
In this study, the investgatiors aimed to investigate the associations between serum levels of stearoyl-CoA desaturase-1(SCD-1) and the disease severity as well as the presence of adverse clinical events, such as local complications, organ failure, mortality and so on.In this prospective study, participants were divided into two groups based on serum SCD-1 concentration on admission and prospectively observe the disease severity and clinical outcomes of them.
Conditions
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2018-12-30
- Completion
- 2019-06-30
- First posted
- 2017-09-13
- Last updated
- 2017-11-27
Source: ClinicalTrials.gov record NCT03282253. Inclusion in this directory is not an endorsement.